'Tranexamic acid' presentation slideshows

Use of Tranexamic Acid to reduce blood loss and Transfusion requirements

Use of Tranexamic Acid to reduce blood loss and Transfusion requirements. Dr.Shaiji.P.S Assistant Professor Dept of Transfusion Medicine Govt.Medical College,Thiruvananthapuram. Background. Bleeding Leading cause of death Major indication for Blood Transfusion world wide Trauma

1k views • 52 slides

Managing ED Anticoagulated Patients with ICH: What is the Optimal Procedure for Anticoagulation Reversal?

Managing ED Anticoagulated Patients with ICH: What is the Optimal Procedure for Anticoagulation Reversal? . Mark I. Langdorf, MD, MHPE Professor and Chair, Department of Emergency Medicine University of California, Irvine. Disclosure. None related to the content of this presentation.

1.22k views • 46 slides

599 views • 46 slides

Acute Intracerebral Hemorrhage: What is the Optimal Therapy in the Anticoagulated Patient?

Acute Intracerebral Hemorrhage: What is the Optimal Therapy in the Anticoagulated Patient? . Chris A. Ghaemmaghami, MD Associate Professor of Emergency Medicine University of Virginia USA.

895 views • 44 slides

What a Bloody Mess!

609 views • 43 slides

Statistical Review of the Observational Studies of Aprotinin Safety Part II: The i3 Drug Safety Study

Statistical Review of the Observational Studies of Aprotinin Safety Part II: The i3 Drug Safety Study. CRDAC and DSaRM Meeting September 12, 2007 P. Chris Holland, M.S. Quantitative Safety and Pharmacoepidemiology Group Office of Biostatistics. Outline. Objective Background

422 views • 32 slides

Jeff Healey

The New Anticoagulants are Here! Do you know how to use them? Arrhythmia Winter School February 11 th , 2012. Jeff Healey. RELY: A New Era in AF. Connolly SJ et al. N Engl J Med 2009;361:1139-1151. ROCKET-AF: Primary Efficacy Outcome Stroke and non-CNS Embolism. Warfarin. Rivaroxaban.

449 views • 32 slides

Trauma Anaesthesia

Trauma Anaesthesia. Dr James Peerless December 2013. Approaching Trauma. Airway + c-spine control Breathing Circulation Disability Exposure Multidisciplinary approach. Session Learning Points. Shock Damage Control Resuscitation GSTT Major Haemorrhage Protocols. Shock. Shock.

842 views • 32 slides

Thromboelastography By Mike Poullis

Thromboelastography By Mike Poullis. Measuring Coagulation Status. Why do it? Benefits Need to understand the position of TEG in coagulation assessment. Techniques. Full blood count and Coagulation screen (APTT, PT, and fibrinogen) Whole Blood tests Microaggregation Whole blood analysers

813 views • 28 slides

Tranexamic Acid In Gynaecology & Obstetrics

1.61k views • 26 slides

STEPS FOR THE MANAGEMENT PPH

STEPS FOR THE MANAGEMENT PPH. OBJECTIVES. Discuss the importance of the Golden Hour Present a follow-up sequence for PPH. STEPS FOR THE MANAGEMENT OF PPH. Early control of the bleeding is the most effective measure for the treatment of PPH.

240 views • 23 slides

TXA in trauma patients: who should we treat and when?

TXA in trauma patients: who should we treat and when?. Tranexamic acid and bleeding. Tranexamic Acid (TXA) is a synthetic derivative of the amino acid lysine. It has a very high affinity for the lysine binding sites of plasminogen .

380 views • 21 slides

TXA in trauma patients: who should we treat and when?

TXA in trauma patients: who should we treat and when?. Tranexamic acid and bleeding. Tranexamic Acid (TXA) is a synthetic derivative of the amino acid lysine. It has a very high affinity for the lysine binding sites of plasminogen .

369 views • 21 slides

The Local Use of Tranexamic Acid Is it a Myth??

The Local Use of Tranexamic Acid Is it a Myth??. Dr. Dina Salah El Din Mahmoud Ass. Prof. of Anesthesia, ICU and Pain management. Ain Shams University Dr. Yasmin Mahmoud Aboul-Ela Lecturer of Clinical Pharmacology, Ain Shams University. Case Report.

505 views • 20 slides

Management of Abnormal Vaginal Bleeding

687 views • 11 slides

HEMOPHILIA

HEMOPHILIA. MISHA MAZHAR 2k10-NUST-BS-V&I-54. OVERVIEW. An inherited bleeding disorder. Occurs in two forms. Hemophilia A. Hemophilia B. WHAT CAUSES HEMOPHILIA?. Mutations in F8 or F9 genes. Leads to lack of proteins made by these genes.

384 views • 11 slides

Menorrhagia

Menorrhagia . Samadhi Reid NPT VTS September 2008. Definition.

486 views • 10 slides

A 37 year-old with Menorrhagia

A 37 year-old with Menorrhagia. Max Brinsmead PhD FRANZCOG March 2010. What are the treatment options for a 37 year-old Para 1 who has menorrhagia and a 5 cm fibroid in the fundus of her uterus? She is a smoker. A 37-year old Para 1 with menorrhagia and a 5 cm fundal fibroid.

354 views • 10 slides

Safe Skin Lightening Products for Pigmentation

While skin pigmentation isn’t a serious medical condition, it can be cosmetically bothersome and affect your self-confidence. Fortunately, there are a number of safe lightening products that can deal with this skin concern and promote better skin tone and texture. - www.drsylviaskincare.com

47 views • 3 slides

The Skin Lightening Supplement that Also Treats Melasma – Proven by Clinical Studies!

Melasma is a type of skin hyperpigmentation common among women between the ages of 20 and 40. It is characterized by tan, brown or grayish patches that appear on the face, cheeks, chin, and forehead. While this condition is harmless, it has a negative effect on self-esteem and quality of life. - https://www.drsylviaskincare.com

99 views • 3 slides